
Product Details
| Model | CG-1 |
| Brand | HER OPTION |
| Category | Cryosurgical Unit |
| Posted | 18.02.2026 |
| Views | 298 |
Used - Good HER OPTION CG-1
Condition:: Used - Good
Availability:: In stock
Shipping from::
USA
200
Seller:
pro USA
We are dedicated to improving healthcare delivery by bridging the gap between excess and need of medical equipment and supplies.
Description
The Her Option™ Cryoablation Therapy System (CG-1) is a closed-cycle cryosurgical device designed for in-office endometrial ablation. It utilizes sub-zero temperatures to destroy the endometrial lining of the uterus, providing a minimally invasive, non-hormonal treatment for pre-menopausal women suffering from menorrhagia (excessive uterine bleeding) due to benign causes and who have completed childbearing. The system is engineered specifically for office-based use, offering patient comfort, a strong safety profile, and a short total treatment time. Most patients can return to normal activities within a day, and the procedure requires only minimal anesthesia without the need for IV sedation or surgery.
Key Features:
Closed-cycle cryosurgical device: Uses extreme cold (–100 to –120°C at the probe tip) to ablate the endometrial lining.
Office-based procedure: Designed for use in a clinic setting, not requiring hospital admission or general anesthesia.
Short treatment and recovery time: Typical procedure lasts 20–25 minutes, with most patients resuming normal activities within hours.
High patient satisfaction: Studies show a 94% effectiveness rate in reducing bleeding, with 20–25% of patients achieving amenorrhea (no periods).
No hormones or surgery required: Provides an alternative to hormone therapy and surgical ablation.
Minimal anesthesia: Most cases require only local anesthesia; IV sedation is not necessary.
Strong safety profile: Low rates of perioperative and postoperative pain and complications.
Contraindications: Not for use in patients who are pregnant, desire future fertility, or have known/suspected endometrial carcinoma or active genital infection.
Components: Includes a console (compressor system, user interface, microprocessor), cryoprobe, and a single-use disposable control unit that covers the cryoprobe during use.
Key Features:
Closed-cycle cryosurgical device: Uses extreme cold (–100 to –120°C at the probe tip) to ablate the endometrial lining.
Office-based procedure: Designed for use in a clinic setting, not requiring hospital admission or general anesthesia.
Short treatment and recovery time: Typical procedure lasts 20–25 minutes, with most patients resuming normal activities within hours.
High patient satisfaction: Studies show a 94% effectiveness rate in reducing bleeding, with 20–25% of patients achieving amenorrhea (no periods).
No hormones or surgery required: Provides an alternative to hormone therapy and surgical ablation.
Minimal anesthesia: Most cases require only local anesthesia; IV sedation is not necessary.
Strong safety profile: Low rates of perioperative and postoperative pain and complications.
Contraindications: Not for use in patients who are pregnant, desire future fertility, or have known/suspected endometrial carcinoma or active genital infection.
Components: Includes a console (compressor system, user interface, microprocessor), cryoprobe, and a single-use disposable control unit that covers the cryoprobe during use.
Didn’t find what you were looking for? Place your own ad on the Bimedis platform
Place your advert on Bimedis and reach buyers worldwide.
